COVID-19 has rocked markets and caused panic across the world. While investors are feeling the pain as global supply chains may become constricted, playing on COVID-19 stocks has proven very lucrative. Companies are developing a vaccine, testing kit or even household cleaning products have proven not only to be safe havens but also savvy investments. However, there are two sides to every trade.
More and more companies are joining the fight against the new coronavirus, and 24/7 Wall St. is taking a look at some of these companies and their most recent short interest data.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected coronavirus stocks increased.
Short interest in Moderna Inc. (NASDAQ: MRNA | MRNA Price Prediction) increased to 20.15 million shares from the previous 17.13 million. The stock was trading at $24.76 Wednesday morning, within a 52-week range of $11.54 to $36.00.
The number of Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) shares short increased to 2.88 million from 2.65 million in the previous period. Its shares were trading at $469.42, in a 52-week range of $271.37 to $500.00.
[nativounit]
Novavax Inc. (NASDAQ: NVAX) saw its short interest decrease to 5.14 million shares from 6.02 million in the prior period. The stock was trading at $10.13. The 52-week range is $3.54 to $17.71.
Gilead Sciences Inc. (NASDAQ: GILD) short interest increased to 23.76 million shares from the previous 21.56 million. Shares traded at $73.73, in a 52-week range of $60.89 to $80.40.
Short interest in NanoViricides Inc. (NYSE: NNVC) increased to 737,500 from the previous 328,200. The stock was trading at $8.33, and its 52-week range is $1.27 to $19.20.
In Lakeland Industries Inc. (NASDAQ: LAKE), short interest increased to 977,800 from the prior 490,000. The stock was trading at $15.72, and the 52-week range is $9.70 to $28.00.
Clorox Co. (NYSE: CLX) short interest rose to 8.94 million shares from the previous 8.70 million. The stock was trading at $171.58. The 52-week range is $144.12 to $178.88.
Co-Diagnostics Inc. (NASDAQ: CODX) short interest rose to 2.46 million shares from the previous 2.18 million. Shares traded at $11.87, in a 52-week range of $0.69 to $21.75.
[recirclink id=651070][wallst_email_signup]
Top Gaining Stocks
Top Losing Stocks